YOLFTbeta
Big Pharma Split Corp Class A

Big Pharma Split Corp Class A

PRM · TO · Financial Services / Asset Management

16.02CAD-0.18 (-1.11%)

Price History

Full chart

Market Stats

Previous Close16.20
Open16.00
Day Range16.00 – 16.02
52-Week Range10.79 – 15.89
Volume500
Market Cap18.78M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.95
Dividend Yield10.66%
Beta0.73
50-Day Avg14.91
200-Day Avg14.27

About

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Company Details

Financials

Income Statement

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue407.11K3.23M2.43M589.26K5.36M3.71M311.76K1.85M1.45M
Growth (%)-+693.91%-24.69%-75.79%+809.51%-30.76%-91.60%+493.09%-21.38%
Cost of Revenue-274.75K238.19K277.31K355.99K419.54K308.57K315.95K313.72K
Gross Profit407.11K2.96M2.20M589.26K5.36M3.71M311.76K1.53M1.14M
Gross Margin100.00%91.50%90.21%100.00%100.00%100.00%100.00%82.91%78.42%
Operating Expense83.89K-2.99M1.74M323.83K505.73K565.13K451.44K1.52M-3.89M
Operating Income323.22K5.95M454.66K265.42K4.85M3.15M-139.68K13.41K5.03M
Operating Margin79.39%184.05%18.68%45.04%90.56%84.77%-44.80%0.73%346.00%
EBITDA323.22K5.95M454.66K265.42K4.85M3.15M-137.56K21.36K5.03M
EBITDA Margin79.39%184.05%18.68%45.04%90.56%84.77%-44.12%1.16%346.00%
Net Income323.22K2.78M5.83M265.42K4.85M3.15M-139.68K-538.62K4.40M
Net Income Margin79.39%86.01%239.67%45.04%90.56%84.77%-44.80%-29.13%302.72%
Interest Expense000482.81K875.41K760.17K507.79K559.98K641.40K
Interest Expense % of Total Revenue0.00%0.00%0.00%81.94%16.33%20.49%162.88%30.28%44.12%

Balance Sheet

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets32.49M33.63M27.18M22.93M37.81M39.10M26.53M26.30M31.84M
Total Liabilities13.81M14.79M10.87M9.75M15.41M19.37M10.68M12.62M13.57M
Total Equity18.68M18.84M16.31M13.19M22.40M19.73M15.85M13.68M18.27M
Cash1.85M417.07K536.06K230.99K1.43M819.21K204.19K1.03M1.35M
Total Debt13.60M13.41M10.58M9.35M14.86M9.85M10.30M11.57M13.17M
Net Debt11.75M12.99M10.05M9.12M13.43M9.04M10.09M10.54M11.82M

Cash Flow

Currency: CAD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-30.95M1.27M8.68M4.35M-9.00M1.13M11.86M-1.30M-1.06M
Financing Cash Flow32.74M-2.71M-8.57M-4.65M10.19M-1.74M-12.47M-346.38K1.81M
Capital Expenditure000300334
Free Cash Flow-30.95M1.27M8.68M4.35M-9.00M1.13M11.86M-1.30M-1.06M
Dividends Paid2.25M2.25M1.48M1.23M2.84M2.62M2.11M1.50M1.51M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF-7.28%177.34%17.10%28.35%-31.51%231.81%17.78%-116.08%-142.85%

Key Statistics & Ratios

Market Cap18.78M
Enterprise Value-9.41M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.27
Price / Book1.07
EPS-1.95
Book Value14.80
Revenue (TTM)9.91M
Gross Profit (TTM)9.91M
Profit Margin68.21%
Operating Margin89.18%
Return on Equity41.49%
Return on Assets19.18%
Shares Outstanding1.31M
Shares Float0
Beta0.73
Dividend Yield10.66%
Dividend Rate1.24
Payout Ratio0.00%

Dividends

20269×
0.10Oct 30, 20260.10Aug 31, 20260.10Jul 31, 20260.10Jun 30, 20260.10May 29, 20260.10Apr 30, 20260.10Mar 31, 20260.10Feb 27, 20260.10Jan 30, 2026
202512×
0.10Dec 31, 20250.10Nov 28, 20250.10Oct 31, 20250.10Sep 29, 20250.10Aug 29, 20250.10Jul 31, 20250.10Jun 30, 20250.10May 30, 20250.10Apr 30, 20250.10Mar 31, 20250.10Feb 28, 20250.10Jan 31, 2025
20243×
0.10Dec 31, 20240.10Nov 29, 20240.10Oct 31, 2024